DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Bliss GVS Pharma Limited — Updates

NSE 2 hrs ago·14 Oct 2026, 1:16 pm

Bliss GVS Pharma

Bliss GVS Pharma has announced that it has been reclassified from the promoter and promoter group category to the public category. This change was officially disclosed to stock exchanges on September 28, 2026, under SEBI Listing Regulations.

This reclassification is a significant corporate event for investors. It means that the shares held by the promoters are now considered public float, increasing the number of freely tradable shares in the market. This can impact the stock's liquidity and volatility as the free float percentage changes.

Investors should monitor the impact of this change on the stock's trading volume and price movement. The increased free float often leads to higher liquidity, but it can also introduce more volatility due to the larger number of shares available for trading.